Company News-News

2025-11-14

Kingsley Leung, Chairman of Great Bay Bio, Awarded the FHKI X OCBC Hong Kong Innopreneur Awards 2025, Recognizing Outstanding Innovation

Recently, the FHKI X OCBC Hong Kong Innopreneur Awards 2025, organized by the Federation of Hong Kong Industries and t

2025-11-11

Great Bay Bio and Taron Form Strategic Partnership to Advance HK Biopharmaceutical Innovation

Hong Kong

2025-06-20

Great Bay Bio and Eureka Therapeutics Partner to Develop AI-Powered Antibody Discovery Model

Great Bay Bio is proud to announce a collaboration with Eureka Therapeutics to co-develop a cutting-edge specialized A

2025-04-14

Great Bay Bio and Chime Biologics Deepen Strategic Collaboration Using AI to Accelerate the Development of Biopharmaceutical

Today, Great Bay Bio (GBB) announced an expanded strategic partnership with Chime Biologics, a global leader in CDMO.

2025-01-21

Great Bay Bio Partners with Prof Chen from MIT to Co-develop Novel Tumor Antibody

Recently, Great Bay Bio (GBB) partnered with Professor JZ Chen from the Koch Institute for Integrative Cancer Research

2025-01-06

Comparison Results of AlfaMedx vs. 17 Commercial Media Released

Great Bay Bio self-developed AI-enabled cell culture media, AlfaMedX (NF3370+DF2025), leverages cutting-edge technologies, including AI, to analyze and predict large volumes of experimental data. This approach optimizes the composition and usage condition

2024-12-30

Great Bay Bio Recognized as One of the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2024

The Guangdong-Hong Kong-Macao Greater Bay Area Biotech Innovation Summit and the 7th Top 50 Innovative Biotech Compani

2024-12-16

Great Bay Bio Completes First Close of Series B Financing

Hong Kong December 16, 2024 Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B